Loading…
Venetoclax combined with daunorubicin and cytarabine (2 + 6) in acute myeloid leukemia: Updated results of a phase II trial
Saved in:
| Published in: | Hematological oncology 2024-07, Vol.42 (4), p.e3296-n/a |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Article |
| Language: | English |
| Subjects: | |
| Citations: | Items that this one cites |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| cited_by | |
|---|---|
| cites | cdi_FETCH-LOGICAL-c2746-5c32ffe1d9be0862bc119482d25b256918521f6bb565ad1d972a75a138012b363 |
| container_end_page | n/a |
| container_issue | 4 |
| container_start_page | e3296 |
| container_title | Hematological oncology |
| container_volume | 42 |
| creator | Suo, Xiaohui Fang, Zheng Wang, Dongmei Zhao, Liyun Liu, Jie Li, Hong Ma, Xiaojun Zhang, Congcong Zhao, Xuemei Shi, Rui Wu, Yan Jiao, Zongjiu Song, Jiaojie Zhang, Ling Li, Ling Zhang, Suping Lu, Xinxiao Yuan, Linyu Gao, Sifeng Zhang, Jilei Liu, Kaiqi Zhao, Xingli Bai, Guanchen Mi, Yingchang |
| description | |
| doi_str_mv | 10.1002/hon.3296 |
| format | article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3083682043</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3083682043</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2746-5c32ffe1d9be0862bc119482d25b256918521f6bb565ad1d972a75a138012b363</originalsourceid><addsrcrecordid>eNp10c9qFTEUx_Egir1WwSeQgJuKTE1ObjIZd1Jse6HYjXU75M8Zbmpmck1mqHfhu_RZ-mTO2KoguMrifPgS-BHykrNjzhi826bhWECjHpEVZ01Tcaaax2TFoNYVAwEH5Fkp14zNN6afkgPRsDVXUqzIjy844JhcNN-pS70NA3p6E8Yt9WYaUp5scGGgZvDU7UeTzSLoEdzdvr27VW_ocnPTiLTfY0zB04jTV-yDeU-vdt6Mcy1jmeJYaOqoobutKUg3GzrmYOJz8qQzseCLh_eQXJ1-_HxyXl1cnm1OPlxUDuq1qqQT0HXIfWORaQXWcd6sNXiQFqRquJbAO2WtVNL4mdVgamm40IyDFUockqP77i6nbxOWse1DcRijGTBNpRVMC6WBrcVMX_9Dr9OUh_l3i5IAdV3rv0GXUykZu3aXQ2_yvuWsXSZp50naZZKZvnoITrZH_wf-3mAG1T24CRH3_w2155effgV_AjOHlLQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3085227778</pqid></control><display><type>article</type><title>Venetoclax combined with daunorubicin and cytarabine (2 + 6) in acute myeloid leukemia: Updated results of a phase II trial</title><source>Wiley-Blackwell Read & Publish Collection</source><creator>Suo, Xiaohui ; Fang, Zheng ; Wang, Dongmei ; Zhao, Liyun ; Liu, Jie ; Li, Hong ; Ma, Xiaojun ; Zhang, Congcong ; Zhao, Xuemei ; Shi, Rui ; Wu, Yan ; Jiao, Zongjiu ; Song, Jiaojie ; Zhang, Ling ; Li, Ling ; Zhang, Suping ; Lu, Xinxiao ; Yuan, Linyu ; Gao, Sifeng ; Zhang, Jilei ; Liu, Kaiqi ; Zhao, Xingli ; Bai, Guanchen ; Mi, Yingchang</creator><creatorcontrib>Suo, Xiaohui ; Fang, Zheng ; Wang, Dongmei ; Zhao, Liyun ; Liu, Jie ; Li, Hong ; Ma, Xiaojun ; Zhang, Congcong ; Zhao, Xuemei ; Shi, Rui ; Wu, Yan ; Jiao, Zongjiu ; Song, Jiaojie ; Zhang, Ling ; Li, Ling ; Zhang, Suping ; Lu, Xinxiao ; Yuan, Linyu ; Gao, Sifeng ; Zhang, Jilei ; Liu, Kaiqi ; Zhao, Xingli ; Bai, Guanchen ; Mi, Yingchang</creatorcontrib><identifier>ISSN: 0278-0232</identifier><identifier>ISSN: 1099-1069</identifier><identifier>EISSN: 1099-1069</identifier><identifier>DOI: 10.1002/hon.3296</identifier><identifier>PMID: 39041653</identifier><language>eng</language><publisher>England: Wiley Subscription Services, Inc</publisher><subject>Acute myeloid leukemia ; Adult ; Aged ; Antineoplastic Combined Chemotherapy Protocols - administration & dosage ; Antineoplastic Combined Chemotherapy Protocols - adverse effects ; Antineoplastic Combined Chemotherapy Protocols - therapeutic use ; Bridged Bicyclo Compounds, Heterocyclic - administration & dosage ; Bridged Bicyclo Compounds, Heterocyclic - therapeutic use ; Cytarabine ; Cytarabine - administration & dosage ; Cytarabine - therapeutic use ; Daunorubicin ; Daunorubicin - administration & dosage ; Female ; Humans ; Leukemia ; Leukemia, Myeloid, Acute - drug therapy ; Male ; Middle Aged ; Sulfonamides - administration & dosage ; Sulfonamides - therapeutic use</subject><ispartof>Hematological oncology, 2024-07, Vol.42 (4), p.e3296-n/a</ispartof><rights>2024 The Author(s). Hematological Oncology published by John Wiley & Sons Ltd.</rights><rights>2024. This article is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c2746-5c32ffe1d9be0862bc119482d25b256918521f6bb565ad1d972a75a138012b363</cites><orcidid>0000-0001-9299-5786 ; 0000-0002-1532-0301</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39041653$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Suo, Xiaohui</creatorcontrib><creatorcontrib>Fang, Zheng</creatorcontrib><creatorcontrib>Wang, Dongmei</creatorcontrib><creatorcontrib>Zhao, Liyun</creatorcontrib><creatorcontrib>Liu, Jie</creatorcontrib><creatorcontrib>Li, Hong</creatorcontrib><creatorcontrib>Ma, Xiaojun</creatorcontrib><creatorcontrib>Zhang, Congcong</creatorcontrib><creatorcontrib>Zhao, Xuemei</creatorcontrib><creatorcontrib>Shi, Rui</creatorcontrib><creatorcontrib>Wu, Yan</creatorcontrib><creatorcontrib>Jiao, Zongjiu</creatorcontrib><creatorcontrib>Song, Jiaojie</creatorcontrib><creatorcontrib>Zhang, Ling</creatorcontrib><creatorcontrib>Li, Ling</creatorcontrib><creatorcontrib>Zhang, Suping</creatorcontrib><creatorcontrib>Lu, Xinxiao</creatorcontrib><creatorcontrib>Yuan, Linyu</creatorcontrib><creatorcontrib>Gao, Sifeng</creatorcontrib><creatorcontrib>Zhang, Jilei</creatorcontrib><creatorcontrib>Liu, Kaiqi</creatorcontrib><creatorcontrib>Zhao, Xingli</creatorcontrib><creatorcontrib>Bai, Guanchen</creatorcontrib><creatorcontrib>Mi, Yingchang</creatorcontrib><title>Venetoclax combined with daunorubicin and cytarabine (2 + 6) in acute myeloid leukemia: Updated results of a phase II trial</title><title>Hematological oncology</title><addtitle>Hematol Oncol</addtitle><subject>Acute myeloid leukemia</subject><subject>Adult</subject><subject>Aged</subject><subject>Antineoplastic Combined Chemotherapy Protocols - administration & dosage</subject><subject>Antineoplastic Combined Chemotherapy Protocols - adverse effects</subject><subject>Antineoplastic Combined Chemotherapy Protocols - therapeutic use</subject><subject>Bridged Bicyclo Compounds, Heterocyclic - administration & dosage</subject><subject>Bridged Bicyclo Compounds, Heterocyclic - therapeutic use</subject><subject>Cytarabine</subject><subject>Cytarabine - administration & dosage</subject><subject>Cytarabine - therapeutic use</subject><subject>Daunorubicin</subject><subject>Daunorubicin - administration & dosage</subject><subject>Female</subject><subject>Humans</subject><subject>Leukemia</subject><subject>Leukemia, Myeloid, Acute - drug therapy</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Sulfonamides - administration & dosage</subject><subject>Sulfonamides - therapeutic use</subject><issn>0278-0232</issn><issn>1099-1069</issn><issn>1099-1069</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><recordid>eNp10c9qFTEUx_Egir1WwSeQgJuKTE1ObjIZd1Jse6HYjXU75M8Zbmpmck1mqHfhu_RZ-mTO2KoguMrifPgS-BHykrNjzhi826bhWECjHpEVZ01Tcaaax2TFoNYVAwEH5Fkp14zNN6afkgPRsDVXUqzIjy844JhcNN-pS70NA3p6E8Yt9WYaUp5scGGgZvDU7UeTzSLoEdzdvr27VW_ocnPTiLTfY0zB04jTV-yDeU-vdt6Mcy1jmeJYaOqoobutKUg3GzrmYOJz8qQzseCLh_eQXJ1-_HxyXl1cnm1OPlxUDuq1qqQT0HXIfWORaQXWcd6sNXiQFqRquJbAO2WtVNL4mdVgamm40IyDFUockqP77i6nbxOWse1DcRijGTBNpRVMC6WBrcVMX_9Dr9OUh_l3i5IAdV3rv0GXUykZu3aXQ2_yvuWsXSZp50naZZKZvnoITrZH_wf-3mAG1T24CRH3_w2155effgV_AjOHlLQ</recordid><startdate>202407</startdate><enddate>202407</enddate><creator>Suo, Xiaohui</creator><creator>Fang, Zheng</creator><creator>Wang, Dongmei</creator><creator>Zhao, Liyun</creator><creator>Liu, Jie</creator><creator>Li, Hong</creator><creator>Ma, Xiaojun</creator><creator>Zhang, Congcong</creator><creator>Zhao, Xuemei</creator><creator>Shi, Rui</creator><creator>Wu, Yan</creator><creator>Jiao, Zongjiu</creator><creator>Song, Jiaojie</creator><creator>Zhang, Ling</creator><creator>Li, Ling</creator><creator>Zhang, Suping</creator><creator>Lu, Xinxiao</creator><creator>Yuan, Linyu</creator><creator>Gao, Sifeng</creator><creator>Zhang, Jilei</creator><creator>Liu, Kaiqi</creator><creator>Zhao, Xingli</creator><creator>Bai, Guanchen</creator><creator>Mi, Yingchang</creator><general>Wiley Subscription Services, Inc</general><scope>24P</scope><scope>WIN</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7QO</scope><scope>7QP</scope><scope>7T7</scope><scope>7TK</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-9299-5786</orcidid><orcidid>https://orcid.org/0000-0002-1532-0301</orcidid></search><sort><creationdate>202407</creationdate><title>Venetoclax combined with daunorubicin and cytarabine (2 + 6) in acute myeloid leukemia: Updated results of a phase II trial</title><author>Suo, Xiaohui ; Fang, Zheng ; Wang, Dongmei ; Zhao, Liyun ; Liu, Jie ; Li, Hong ; Ma, Xiaojun ; Zhang, Congcong ; Zhao, Xuemei ; Shi, Rui ; Wu, Yan ; Jiao, Zongjiu ; Song, Jiaojie ; Zhang, Ling ; Li, Ling ; Zhang, Suping ; Lu, Xinxiao ; Yuan, Linyu ; Gao, Sifeng ; Zhang, Jilei ; Liu, Kaiqi ; Zhao, Xingli ; Bai, Guanchen ; Mi, Yingchang</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2746-5c32ffe1d9be0862bc119482d25b256918521f6bb565ad1d972a75a138012b363</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Acute myeloid leukemia</topic><topic>Adult</topic><topic>Aged</topic><topic>Antineoplastic Combined Chemotherapy Protocols - administration & dosage</topic><topic>Antineoplastic Combined Chemotherapy Protocols - adverse effects</topic><topic>Antineoplastic Combined Chemotherapy Protocols - therapeutic use</topic><topic>Bridged Bicyclo Compounds, Heterocyclic - administration & dosage</topic><topic>Bridged Bicyclo Compounds, Heterocyclic - therapeutic use</topic><topic>Cytarabine</topic><topic>Cytarabine - administration & dosage</topic><topic>Cytarabine - therapeutic use</topic><topic>Daunorubicin</topic><topic>Daunorubicin - administration & dosage</topic><topic>Female</topic><topic>Humans</topic><topic>Leukemia</topic><topic>Leukemia, Myeloid, Acute - drug therapy</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Sulfonamides - administration & dosage</topic><topic>Sulfonamides - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Suo, Xiaohui</creatorcontrib><creatorcontrib>Fang, Zheng</creatorcontrib><creatorcontrib>Wang, Dongmei</creatorcontrib><creatorcontrib>Zhao, Liyun</creatorcontrib><creatorcontrib>Liu, Jie</creatorcontrib><creatorcontrib>Li, Hong</creatorcontrib><creatorcontrib>Ma, Xiaojun</creatorcontrib><creatorcontrib>Zhang, Congcong</creatorcontrib><creatorcontrib>Zhao, Xuemei</creatorcontrib><creatorcontrib>Shi, Rui</creatorcontrib><creatorcontrib>Wu, Yan</creatorcontrib><creatorcontrib>Jiao, Zongjiu</creatorcontrib><creatorcontrib>Song, Jiaojie</creatorcontrib><creatorcontrib>Zhang, Ling</creatorcontrib><creatorcontrib>Li, Ling</creatorcontrib><creatorcontrib>Zhang, Suping</creatorcontrib><creatorcontrib>Lu, Xinxiao</creatorcontrib><creatorcontrib>Yuan, Linyu</creatorcontrib><creatorcontrib>Gao, Sifeng</creatorcontrib><creatorcontrib>Zhang, Jilei</creatorcontrib><creatorcontrib>Liu, Kaiqi</creatorcontrib><creatorcontrib>Zhao, Xingli</creatorcontrib><creatorcontrib>Bai, Guanchen</creatorcontrib><creatorcontrib>Mi, Yingchang</creatorcontrib><collection>Wiley Open Access</collection><collection>Wiley Online Library Free Content</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Neurosciences Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Hematological oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Suo, Xiaohui</au><au>Fang, Zheng</au><au>Wang, Dongmei</au><au>Zhao, Liyun</au><au>Liu, Jie</au><au>Li, Hong</au><au>Ma, Xiaojun</au><au>Zhang, Congcong</au><au>Zhao, Xuemei</au><au>Shi, Rui</au><au>Wu, Yan</au><au>Jiao, Zongjiu</au><au>Song, Jiaojie</au><au>Zhang, Ling</au><au>Li, Ling</au><au>Zhang, Suping</au><au>Lu, Xinxiao</au><au>Yuan, Linyu</au><au>Gao, Sifeng</au><au>Zhang, Jilei</au><au>Liu, Kaiqi</au><au>Zhao, Xingli</au><au>Bai, Guanchen</au><au>Mi, Yingchang</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Venetoclax combined with daunorubicin and cytarabine (2 + 6) in acute myeloid leukemia: Updated results of a phase II trial</atitle><jtitle>Hematological oncology</jtitle><addtitle>Hematol Oncol</addtitle><date>2024-07</date><risdate>2024</risdate><volume>42</volume><issue>4</issue><spage>e3296</spage><epage>n/a</epage><pages>e3296-n/a</pages><issn>0278-0232</issn><issn>1099-1069</issn><eissn>1099-1069</eissn><cop>England</cop><pub>Wiley Subscription Services, Inc</pub><pmid>39041653</pmid><doi>10.1002/hon.3296</doi><tpages>4</tpages><orcidid>https://orcid.org/0000-0001-9299-5786</orcidid><orcidid>https://orcid.org/0000-0002-1532-0301</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0278-0232 |
| ispartof | Hematological oncology, 2024-07, Vol.42 (4), p.e3296-n/a |
| issn | 0278-0232 1099-1069 1099-1069 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_3083682043 |
| source | Wiley-Blackwell Read & Publish Collection |
| subjects | Acute myeloid leukemia Adult Aged Antineoplastic Combined Chemotherapy Protocols - administration & dosage Antineoplastic Combined Chemotherapy Protocols - adverse effects Antineoplastic Combined Chemotherapy Protocols - therapeutic use Bridged Bicyclo Compounds, Heterocyclic - administration & dosage Bridged Bicyclo Compounds, Heterocyclic - therapeutic use Cytarabine Cytarabine - administration & dosage Cytarabine - therapeutic use Daunorubicin Daunorubicin - administration & dosage Female Humans Leukemia Leukemia, Myeloid, Acute - drug therapy Male Middle Aged Sulfonamides - administration & dosage Sulfonamides - therapeutic use |
| title | Venetoclax combined with daunorubicin and cytarabine (2 + 6) in acute myeloid leukemia: Updated results of a phase II trial |
| url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T20%3A20%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Venetoclax%20combined%20with%20daunorubicin%20and%20cytarabine%20(2%C2%A0+%C2%A06)%20in%20acute%20myeloid%20leukemia:%20Updated%20results%20of%20a%20phase%20II%20trial&rft.jtitle=Hematological%20oncology&rft.au=Suo,%20Xiaohui&rft.date=2024-07&rft.volume=42&rft.issue=4&rft.spage=e3296&rft.epage=n/a&rft.pages=e3296-n/a&rft.issn=0278-0232&rft.eissn=1099-1069&rft_id=info:doi/10.1002/hon.3296&rft_dat=%3Cproquest_cross%3E3083682043%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c2746-5c32ffe1d9be0862bc119482d25b256918521f6bb565ad1d972a75a138012b363%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3085227778&rft_id=info:pmid/39041653&rfr_iscdi=true |